CD30 molecule (Ki-1 Ag): more than just a marker of CD30+ lymphoma.
Pizzolo
G
G
Cattedra di Ematologia, University of Verona, Italy.
Romagnani
S
S
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000097:blood*; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood*; D053285:CD30 Ligand; D006509:Hepatitis B / Q000097:blood; D006689:Hodgkin Disease / Q000097:blood* / Q000628:therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D017730:Ki-1 Antigen / Q000097:blood / Q000235:genetics / Q000502:physiology*; D008213:Lymphocyte Activation; D017728:Lymphoma, Large-Cell, Anaplastic / Q000097:blood* / Q000628:therapy; D008562:Membrane Glycoproteins / Q000378:metabolism*; D051379:Mice; D005810:Multigene Family; D051381:Rats; D018418:Th2 Cells / Q000166:cytology / Q000378:metabolism
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D015415:Biomarkers; D014408:Biomarkers, Tumor; D053285:CD30 Ligand; D017730:Ki-1 Antigen; D008562:Membrane Glycoproteins; C505774:TNFSF8 protein, human; C505775:Tnfsf8 protein, mouse